
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $128.6M | -- | -- | $0.38 | -- |
07/31/2025 | Q2 | $117.9M | -- | -- | $0.38 | -- |
04/30/2025 | Q1 | $148M | $135.7M | $0.46 | $0.65 | -$0.19 |
02/19/2025 | Q4 | $137.8M | $145.8M | $0.62 | $0.62 | -- |
10/30/2024 | Q3 | $137.1M | $122.3M | $0.28 | $0.56 | -$0.28 |
07/31/2024 | Q2 | $137.6M | $130.8M | $0.47 | $0.76 | -$0.29 |
05/07/2024 | Q1 | $153.4M | $136.8M | $0.40 | $0.84 | -$0.44 |
02/21/2024 | Q4 | $133.8M | $130.6M | $0.58 | $0.67 | -$0.09 |
11/01/2023 | Q3 | -- | -- | $0.42 | $0.88 | -$0.46 |
08/02/2023 | Q2 | -- | -- | $0.91 | $0.80 | $0.11 |
05/03/2023 | Q1 | -- | -- | $0.81 | $0.97 | -$0.16 |
02/22/2023 | Q4 | -- | -- | $1.06 | $0.98 | $0.08 |
11/02/2022 | Q3 | -- | -- | $1.03 | $1.14 | -$0.11 |
08/03/2022 | Q2 | -- | -- | $1.17 | $1.50 | -$0.33 |
05/04/2022 | Q1 | -- | -- | $1.70 | $1.73 | -$0.03 |
02/23/2022 | Q4 | -- | -- | $2.14 | $1.94 | $0.21 |
11/03/2021 | Q3 | -- | -- | $1.98 | $2.18 | -$0.20 |
08/04/2021 | Q2 | -- | -- | $2.50 | $1.73 | $0.78 |
05/05/2021 | Q1 | -- | -- | $2.16 | $1.44 | $0.73 |
02/17/2021 | Q4 | -- | -- | $1.78 | $1.19 | $0.59 |
10/28/2020 | Q3 | -- | -- | $1.39 | $0.98 | $0.42 |
07/29/2020 | Q2 | -- | -- | $1.05 | $1.23 | -$0.18 |
05/06/2020 | Q1 | -- | -- | $0.87 | $0.72 | $0.15 |
02/19/2020 | Q4 | -- | -- | $0.45 | -- | -- |
11/07/2019 | Q3 | -- | -- | $0.27 | -- | -- |
07/31/2019 | Q2 | -- | -- | $0.35 | -- | -- |
05/07/2019 | Q1 | -- | -- | $0.74 | -- | -- |
02/20/2019 | Q4 | -- | -- | $0.69 | $0.79 | -$0.10 |
10/31/2018 | Q3 | -- | -- | $0.52 | $0.92 | -$0.40 |
08/01/2018 | Q2 | -- | -- | $0.86 | -- | -- |
05/08/2018 | Q1 | -- | -- | $0.81 | -- | -- |
02/21/2018 | Q4 | -- | -- | $0.59 | -- | -- |
10/31/2017 | Q3 | -- | -- | $0.53 | -- | -- |
08/02/2017 | Q2 | -- | -- | $0.57 | -- | -- |
05/08/2017 | Q1 | -- | -- | $1.21 | -- | -- |
02/22/2017 | Q4 | -- | -- | $1.11 | -- | -- |
11/01/2016 | Q3 | -- | -- | $1.03 | -- | -- |
08/02/2016 | Q2 | -- | -- | $1.22 | -- | -- |
05/03/2016 | Q1 | -- | -- | $1.21 | -- | -- |
02/25/2016 | Q4 | -- | -- | $0.88 | -- | -- |
11/04/2015 | Q3 | -- | -- | $0.62 | -- | -- |
Sturm Ruger & reported $135.7M worth of top line sales in its most recent quarter.
Sturm Ruger & announced earnings per share of $0.46 which represents a miss of analyst forecast a $0.65 per share.
Sturm Ruger & reported $29.9M that represents $1.77 per share over the last quarter.
Sturm Ruger &'s earnings are forecast to grow from $1.77 per share to $1.76 per share next year representing an increase of 17.51%.
Sturm Ruger &'s next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.